Memantine Hydrochloride Tablet
Product Images NDC 50090-6400

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 50090-6400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine-figure1 (Memantine Figure1)

The text describes a table showing the mean change from the baseline in ADCS-ADL score after 12 weeks of treatment with either placebo or memantine hydrachloride. There may also be information regarding clinical improvement or decline.*

FDA Label Image

Memantine-figure3 (Memantine Figure3)

FDA Label Image

Memantine-figure5 (Memantine Figure5)

FDA Label Image

Memantine-figure7 (Memantine Figure7)

The text is a chart showing the mean (+ SEM) change from baseline in SIB score for placebo/donepezil and memantine hydrochloride donepezil over weeks of treatment.*

FDA Label Image

Memantine_structure (Memantine Structure)

FDA Label Image

Label Image (Lbl500906400)

FDA Label Image

Memantine-figure2 (Memantine Figure2)

FDA Label Image

Memantine-figure4 (Memantine Figure4)

FDA Label Image

Memantine-figure6 (Memantine Figure6)

FDA Label Image

Memantine-figure8 (Memantine Figure8)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.